Literature DB >> 27895783

Curcumin suppresses colon cancer cell invasion via AMPK-induced inhibition of NF-κB, uPA activator and MMP9.

Weihua Tong1, Quan Wang1, Donghui Sun1, Jian Suo1.   

Abstract

Curcumin, an active nontoxic ingredient of turmeric, possesses potent anti-inflammatory, antioxidant and anti-cancer properties; however, the molecular mechanisms of curcumin are not fully understood. The transcription factor nuclear factor-κB (NF-κB) is key in cellular processes, and the expression/activation of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP9) are crucial for cell invasion. The present study investigated the hypothesis that curcumin inhibits colon cancer cell invasion by modulating NF-κB-mediated expression and activation of uPA and MMP9. Human colon cancer SW480 and LoVo cells were treated with various concentrations of curcumin. Curcumin was demonstrated to dose-dependently inhibit the adhesion and proliferation ability of LoVo and SW480 cells using Transwell and MTT assays, respectively. In addition, curcumin activated 5' AMP-activated protein kinase (AMPK) and suppressed p65 NF-κB phosphorylation, as shown by western blot analysis. Compound C, a potent AMPK inhibitor, abolished curcumin-induced inhibition of NF-κB, uPA and MMP9, suggesting that AMPK activation is responsible for curcumin-mediated NF-κB, uPA and MMP9 inhibition. The binding activity of NF-κB to DNA was examined and western blotting and quantitative polymerase reaction was performed to detect the effect of curcumin on the expression of uPA and MMP9. The present results revealed that curcumin significantly decreased the expression of uPA and MMP9 and NF-κB DNA binding activity. Furthermore, curcumin decreased the level of the p65 subunit of NF-κB binding to the promoter of the gene encoding uPA and MMP9, which suppressed transcriptional activation of uPA and MMP9. Overall, the present data suggest that curcumin inhibits colon cancer cell invasion via AMPK activation and subsequent inhibition of p65 NF-κB, uPA and MMP9. The therapeutic potential of curcumin for colon cancer metastasis required additional study.

Entities:  

Keywords:  colon cancer; curcumin; matrix metalloproteinases; nuclear factor-kB; urokinase-type plaminogen activator

Year:  2016        PMID: 27895783      PMCID: PMC5104244          DOI: 10.3892/ol.2016.5148

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  56 in total

1.  Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation.

Authors:  A Kumar; S Dhawan; N J Hardegen; B B Aggarwal
Journal:  Biochem Pharmacol       Date:  1998-03-15       Impact factor: 5.858

2.  Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways.

Authors:  Hong Zong; Feng Wang; Qing-Xia Fan; Liu-Xing Wang
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

3.  Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells.

Authors:  H Chen; Z S Zhang; Y L Zhang; D Y Zhou
Journal:  Anticancer Res       Date:  1999 Sep-Oct       Impact factor: 2.480

4.  Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B.

Authors:  R Mohan; J Sivak; P Ashton; L A Russo; B Q Pham; N Kasahara; M B Raizman; M E Fini
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

Review 5.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors:  Roopali Roy; Jiang Yang; Marsha A Moses
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

Review 6.  The plasminogen activation system in tumor growth, invasion, and metastasis.

Authors:  P A Andreasen; R Egelund; H H Petersen
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

7.  Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

Authors:  T Kawamori; R Lubet; V E Steele; G J Kelloff; R B Kaskey; C V Rao; B S Reddy
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

8.  Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.

Authors:  Keishi Tsunoda; Gaspar Kitange; Takeo Anda; Hamisi Kimaro Shabani; Makio Kaminogo; Shobu Shibata; Izumi Nagata
Journal:  Brain Tumor Pathol       Date:  2005       Impact factor: 3.298

9.  Prevention of metastasis by inhibition of the urokinase receptor.

Authors:  C W Crowley; R L Cohen; B K Lucas; G Liu; M A Shuman; A D Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

10.  Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.

Authors:  K J Newell; J P Witty; W H Rodgers; L M Matrisian
Journal:  Mol Carcinog       Date:  1994-08       Impact factor: 4.784

View more
  35 in total

1.  Antitumor effects of curcumin in human bladder cancer in vitro.

Authors:  Jing Shi; Xu Zhang; Taoping Shi; Hongzhao Li
Journal:  Oncol Lett       Date:  2017-05-18       Impact factor: 2.967

2.  Curcumin may induce lipolysis via proteo-stress in Huh7 human hepatoma cells.

Authors:  Cindy Valentine; Kohta Ohnishi; Kazuhiro Irie; Akira Murakami
Journal:  J Clin Biochem Nutr       Date:  2019-09-01       Impact factor: 3.114

Review 3.  Updated Review on the Role of Curcumin in Gastrointestinal Cancers.

Authors:  Melika Naji; Setareh Soroudi; Maryam Akaberi; Amirhossein Sahebkar; Seyed Ahmad Emami
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.

Authors:  Ji Wang; Chunying Wang; Gaofeng Bu
Journal:  Exp Ther Med       Date:  2018-01-29       Impact factor: 2.447

Review 5.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

Review 6.  Natural Medicinal Compounds in Bone Tissue Engineering.

Authors:  Susmita Bose; Naboneeta Sarkar
Journal:  Trends Biotechnol       Date:  2019-12-25       Impact factor: 19.536

7.  Effects of Photosensitization of Curcumin in Human Glioblastoma Multiforme Cells.

Authors:  Aleksander Kielbik; Piotr Wawryka; Dawid Przystupski; Joanna Rossowska; Anna Szewczyk; Jolanta Saczko; Julita Kulbacka; Agnieszka Chwiłkowska
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

8.  Prognostic Score Model Based on Ten Differentially Methylated Genes for Predicting Clinical Outcomes in Patients with Adenocarcinoma of the Colon.

Authors:  Gongping Sun; He Duan; Yuanhao Xing; Dewei Zhang
Journal:  Cancer Manag Res       Date:  2021-06-28       Impact factor: 3.989

9.  Colorectal Adenocarcinoma Cell Culture in a Microfluidically Controlled Environment with a Static Molecular Gradient of Polyphenol.

Authors:  Roman G Szafran; Kazimierz Gąsiorowski; Benita Wiatrak
Journal:  Molecules       Date:  2021-05-27       Impact factor: 4.411

Review 10.  Curcumin and colorectal cancer: An update and current perspective on this natural medicine.

Authors:  Wenhao Weng; Ajay Goel
Journal:  Semin Cancer Biol       Date:  2020-02-20       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.